Skip to main content
OpenTrials
Completed

NCT Number: NCT03335475

Congenital Heart Disease Physical Activity Lifestyle Study

This study will adapt a physical activity lifestyle intervention to adolescent and emerging adult congenital heart disease (CHD) survivors with the primary goal of increasing physical activity levels.

The study will be split into 2 phases. In Phase 1, participants will be asked to complete questionnaires, wear an accelerometer around the waist for 7 days, and undergo an exercise stress test. The accelerometer and exercise stress test will be used to determine whether participants are eligible to be randomized for the intervention study. For adolescent participants, a parent will be asked to complete questionnaires at baseline as well. In Phase 2, participants will be randomized to one of two conditions: 1) receiving a physical activity tracker (a Fitbit) or 2) receiving a Fitbit AND engaging in videoconferencing sessions with a physical activity coach. During Phase 2, participants will also be asked to complete 3 assessments (weeks 9 and 22, and a 6-month follow-up). The week 9 assessment will consist of completing questionnaires and wearing an accelerometer for 7 days. Week 22 will be similar to week 9 with the addition of a final exercise stress test. The 6-month follow-up will mirror the week 9 assessment. For adolescent participants, the same parent will be asked to complete questionnaires at the final assessment as well.

Participants who are randomized to the videoconferencing condition will be asked to meet with a physical activity coach 8 times over the course of 20 weeks. Coaches will help participants to (1) change attitudes toward physical activity, (2) increase perception of others' approval of physical activity (e.g., family members, peers), and (3) increase participants' perceived control by troubleshooting barriers and increasing efficacy for physical activity. Coaches will use the Fitbit to facilitate self-monitoring and goal setting. Participants in the intervention arm will be asked to participate in a focus group at the conclusion of the study to share their experiences.

Completed

Looking for future studies?

Notify Me

Key information

Age range

15 year–18 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Nationwide Children's Hospital

Columbus, Ohio, 43205, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Between the ages of 15-18 (if 18, must be in high school and/or still living at home)
  • Are diagnosed with moderate or complex structural congenital heart disease
  • Live within 120 miles of Nationwide Children's Hospital

Exclusion criteria

  • Do no speak or write proficiently in English
  • Have cognitive impairments that would interfere with the completion of study procedures
  • Are diagnosed with a genetic syndrome (e.g., Downs, Marfans)
  • Have been engaged in a formal exercise program within the past 6 months
  • Underwent open-heart surgery or have had a transcatheter valve replacement in the last 3 months
  • Are otherwise prohibited by their cardiologist to engage in at least moderate levels of physical activity
  • Are unable to complete a treadmill-based exercise stress test
  • Are currently pregnant
  • Have contraindications for exercise based on an exercise stress test (e.g., exercise-induced arrhythmias or evidence of cardiac ischemia)
  • >60 min/day of moderate-to-vigorous physical activity per the accelerometer
  • Do not have internet access or a device for videoconferencing with a PA coach

Treatment and study plan

Physical Activity Lifestyle Intervention

Behavioral

Coaches work with participants on three elements of behaviors change: (1) changing attitudes towards physical activity; (2) increase perceptions of other people's approval of physical activity for the participants; (3) increase perceptions of control over being physically active. These elements will be delivered using a non-judgmental stance accompanied by promoting appropriate goal-setting.

Physical activity monitoring

Behavioral

A physical activity monitor (Fitbit) will be provided to both groups.

Other names: Fitbit

Primary outcomes

  1. Moderate to Vigorous Physical Activity (MVPA)

    Time frame: From baseline to follow-up (approximately 22 weeks).

    Baseline to follow-up change in number of minutes spent in moderate to vigorous physical activity as measured by an accelerometer

Secondary outcomes

  1. Sedentary Behavior

    Time frame: From baseline to follow-up (approximately 22 weeks).

    Baseline to follow-up change in number of minutes spent being sedentary as measured by an accelerometer.

  2. Exercise Tolerance

    Time frame: From baseline to follow-up (approximately 22 weeks).

    Baseline to follow-up change in maximal oxygen utilization during physical activity as measured by VO2peak during an exercise stress test.

Sponsors and collaborators

Lead sponsor

Jamie Jackson

Other

Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

Registry information

Acronym: CHD-PALS

Important dates

Study start
2017
Primary completion
2021
Study completion
2021
First posted
Nov 7, 2017
Registry last updated
May 3, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.